Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Michalet

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
BMC Medical Ethics|April 10, 2024
Oncologists' perspective on advance directives, a French national prospective cross-sectional survey - the ADORE studyAmélie Cambriel, Kevin Serey, Adrien Pollina-Bachellerie, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 20, 2024
Radiation-induced lymphocyte apoptosis assay: Primetime for routine clinical use?David Azria, Morgan Michalet, Olivier Riou, et al.
Advances in Radiation Oncology|October 14, 2021
Magnetic Resonance-Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry StudyMorgan Michalet, Olivier Riou, Simon Valdenaire, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2025
Magnetic resonance guided stereotactic reirradiation for locally recurrent prostate cancers: Long-term results from a prospective registry studyChloé Buchalet, Olivier Riou, Rémi Colin, et al.
Cancers|October 13, 2021
Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular CarcinomaMarie Cantaloube, Florence Castan, Morgane Creoff, et al.
Cancers|April 23, 2022
Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry StudyMorgan Michalet, Olivier Riou, Jeremy Cottet-Moine, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 14, 2026
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trialMorgan Michalet, Philippe Ronchin, Thomas Reynaud, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2023
A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumorsKarl Bordeau, Morgan Michalet, Valérie Dorion, et al.
Frontiers in Oncology|March 31, 2022
Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry StudyMorgan Michalet, Karl Bordeau, Marie Cantaloube, et al.
Cancers|January 8, 2023
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry StudyKarl Bordeau, Morgan Michalet, Aïcha Keskes, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
BMC Medical Ethics|April 10, 2024
Oncologists' perspective on advance directives, a French national prospective cross-sectional survey - the ADORE studyAmélie Cambriel, Kevin Serey, Adrien Pollina-Bachellerie, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 20, 2024
Radiation-induced lymphocyte apoptosis assay: Primetime for routine clinical use?David Azria, Morgan Michalet, Olivier Riou, et al.
Advances in Radiation Oncology|October 14, 2021
Magnetic Resonance-Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry StudyMorgan Michalet, Olivier Riou, Simon Valdenaire, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2025
Magnetic resonance guided stereotactic reirradiation for locally recurrent prostate cancers: Long-term results from a prospective registry studyChloé Buchalet, Olivier Riou, Rémi Colin, et al.
Cancers|October 13, 2021
Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular CarcinomaMarie Cantaloube, Florence Castan, Morgane Creoff, et al.
Cancers|April 23, 2022
Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry StudyMorgan Michalet, Olivier Riou, Jeremy Cottet-Moine, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 14, 2026
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trialMorgan Michalet, Philippe Ronchin, Thomas Reynaud, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2023
A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumorsKarl Bordeau, Morgan Michalet, Valérie Dorion, et al.
Frontiers in Oncology|March 31, 2022
Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry StudyMorgan Michalet, Karl Bordeau, Marie Cantaloube, et al.
Cancers|January 8, 2023
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry StudyKarl Bordeau, Morgan Michalet, Aïcha Keskes, et al.
Pageof 3